Drugs / Kinrix
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00871117 | Mar 2009 → Jan 2010 | diphtheria, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01621802 Background | Jun 2012 → Jul 2015 | viral infectious disease | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kinrix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00871117 ↗ |
| Modality | Vaccine | “DTaP-IPV vaccine (Kinrix®)” NCT01621802 ↗ |
| Route | Intramuscular | “One dose as intramuscular injection at visit 1” NCT00871117 ↗ |